Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors

Fertility and Sterility

Volumn 81, Issue 4, 2004, Pages 1062-1066

  Bodner, Klaus ^a   Bodner Adler, Barbara ^a   Kimberger, Oliver ^a   Czerwenka, Klaus ^a   Mayerhofer, Klaus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Estrogen receptors; Progesterone receptors; Uterine smooth muscle tumors

Indexed keywords

ESTROGEN RECEPTOR; FORMALDEHYDE; PARAFFIN; PROGESTERONE RECEPTOR;

ARTICLE; AUSTRIA; CANCER RISK; CELL COUNT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; GYNECOLOGY; HISTOPATHOLOGY; HOSPITAL DEPARTMENT; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MYOMETRIUM; PARAMETER; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STAINING; STATISTICAL SIGNIFICANCE; TISSUE SECTION; TUMOR CELL; UTERUS MYOMA; UTERUS TUMOR;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SMOOTH MUSCLE TUMOR; STAINING AND LABELING; UTERINE NEOPLASMS;

EID: 1842474854     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2003.08.043     Document Type: Article

References (26)

1. Mittal K., Demopoulos R.I. MIB-1 (KI-67), p 53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Human Pathol. 32:(9):2001;984-987.
2. Clement P.B. The pathology of uterine smooth muscle tumors and mixed endometrial stromal smooth muscle tumors a selective review with emphasis on recent advances. Int J Gynecol Pathol. 19:2000;39-55.
3. Zaloudek C.J., Norris H.J. Mesenchymal tumors of the uterus. Kurman R.J. Blaustein's pathology of the female genital tract. 1994;488-500 Springer-Verlag, New York.
4. Vollenhoven B.J., Lawrence A.S., Healy D.L. Uterine fibroids a clinical review. Br J Obstet Gynecol. 97:1990;285-298.
5. Buttram V.C., Reiter R.C. Uterine leiomyomata etiology, symptomatology, and management. Fertil Steril. 36:1981;433-445.
6. Kawaguchi K., Fujii S., Konishi I., Nanbu Y., Nonokaki H., Mori T. Mitotic activity in uterine leiomyoma during the menstrual cycle. Am J Obstet Gynecol. 160:1989;637-641.
7. Kawaguchi K., Fujii S., Konishi I., et al. Immunohistochemical analysis of oestrogen receptors, progesterone receptors and KI-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy. Virchows Arch Pathol Anat. 419:1991;309-315.
8. Brandon D.D., Bethea C.L., Strawn E.J., et al. Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol. 169:1993;78-85.
9. Zhai Y.L., Kobayashi Y., Mori A., Orii A., Nikaido T., Konishi I., et al. Expression of steroid receptors, KI-67, and p 53 in uterine leiomyosarcomas. Int J Gynecol Pathol. 18:1999;20-28.
10. Zaloudek C.J., Norris H.J. Mesenchymal tumors of the uterus. Kurman R.J. Blaustein's pathology of the female genital tract. 1994;849-914 Springer-Verlag, New York.
11. Schwartz Z., Dgani R., Lancet M., Kessler I. Uterine sarcoma in Israel a study of 104 Cases. Gynecol Oncol. 20:1985;354-363.
12. Evans H.L., Chawla S.P., Simpson C., Finn K.P. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer. 62:1988;2239-2247.
13. Nordal R.R., Kristensen G.B., Kaern J., Stenwig A.E., Pettersen E.O., Trope C.G. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma. Acta Oncol. 34:1995;797-802.
14. Bodner K., Bodner-Adler B., Kimberger O., Czerwenka K., Leodolter S., Mayerhofer K. Evaluating prognostic parameters in women with uterine leiomyosarcomas. A clinicopathologic study. J Reprod Med. 48:(2):2003;95-100.
15. Van Dinh T., Woodruff J.O. Leiomyosarcoma of the uterus. Am J Obstet Gynecol. 144:1982;817-823.
16. Silverberg S.G. Leiomyosarcoma of the uterus. A clinicopathologic study. Obstet Gynecol. 38:1971;613-628.
17. Montague A., Swartz D.P., Woodruff J.D. Sarcoma arising in leiomyoma of the uterus. Am J Obstet Gynecol. 92:1965;421-427.
18. Bodner K., Bodner-Adler B., Kimberger O., Czerwenka K., Leodolter S., Mayerhofer K. Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathologic parameters. Anticancer Res. 23:2003;729-732.
19. Lantta M., Kärkkäinen J., Wahlström T., Widholm O. Estradiol and progesterone receptors in gynecologic sarcomas. Acta Obstet Gynecol Scand. 63:1984;505-508.
20. Wade K., Hammond I., Williams K., Cauchi M. Uterine sarcoma steroid receptors and response to hormonal therapy. Gynecol Oncol. 39:1990;364-367.
21. Sutton G.P., Stehman F.B., Michael H., Young P.C., Ehrlich C.E. Estrogen and progesterone receptors in uterine sarcomas. Obstet Gynecol. 68:1986;709-715.
22. Soper J.T., McCarthy K.S., Hinshaw W., Creasman W.T., Clar-Pearson D.L. Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas. Am J Obstet Gynecol. 150:1984;342-348.
23. Bell S.W., Kempson R.L., Hendrickson M.R. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 18:(6):1994;535-558.
24. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Ass. 53:1958;457-481.
25. Kauppilla A., Kujansuu E., Vihko R. Cytosol estrogen and progestin receptors in endometrial carcinoma of patients treated with surgery, radiotherapy and progestin. Clinical correlates. Cancer. 20:1982;2157-2162.
26. Osborne C.K., Yochmowitz M.G., Knight W.A., McGiure W.L. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer. 46:1980;2884-2888.